Minimally invasive ultrasound-guided carpal tunnel release: long-term clinical outcomes.

IF 2.9 3区医学 Q1 ACOUSTICS

Ultraschall in Der Medizin Pub Date : 2025-09-08 DOI:10.1055/a-2678-8214

Sarah Honold, Alexander Loizides, Elisabeth Skalla, Leonhard Gruber, Michaela Plaikner, Hannes Gruber

{"title":"Minimally invasive ultrasound-guided carpal tunnel release: long-term clinical outcomes.","authors":"Sarah Honold, Alexander Loizides, Elisabeth Skalla, Leonhard Gruber, Michaela Plaikner, Hannes Gruber","doi":"10.1055/a-2678-8214","DOIUrl":null,"url":null,"abstract":"<p><p>In cases of severe or refractory carpal tunnel syndrome (CTS), carpal tunnel release (CTR) can be performed using open surgery, endoscopic techniques, or minimally invasive approaches under high-resolution ultrasound (HRUS) guidance. This study aimed to evaluate the long-term clinical outcomes following HRUS-guided CTR.A retrospective analysis was conducted on 302 HRUS-CTR cases. Patients who were available for a phone interview and had a minimum follow-up period of one year were assessed using the Boston Carpal Tunnel Questionnaire (BCTQ). Symptom severity and functional limitations were compared before and after the procedure.Of the 302 cases screened, 111 cases had to be excluded due to unavailability for the phone call, missing data, or death. Accordingly, 191 cases were included. The average patient age was 60.4 ± 15.5 years (range: 19 to 87 years). 126 cases (66%) were female and 65 cases (34.0%) were male. Overall, there was a significant reduction of 91.9% in CTS-related symptom severity and frequency for all items recorded in the questionnaire. Similarly, a significant reduction of 84.8% in difficulty with all self-reported daily activities was found. In addition, the procedures were performed by four physicians showing no significant differences in technical success and symptoms reduction.HRUS-CTR is a safe and effective method for the treatment of CTS, showing a statistically but mostly clinically significant reduction in symptom severity and hand discomfort, which persisted 1 year after release and should therefore be considered as an alternative approach to open or endoscopic CTR.</p>","PeriodicalId":49400,"journal":{"name":"Ultraschall in Der Medizin","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ultraschall in Der Medizin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2678-8214","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ACOUSTICS","Score":null,"Total":0}

引用次数: 0

Abstract

In cases of severe or refractory carpal tunnel syndrome (CTS), carpal tunnel release (CTR) can be performed using open surgery, endoscopic techniques, or minimally invasive approaches under high-resolution ultrasound (HRUS) guidance. This study aimed to evaluate the long-term clinical outcomes following HRUS-guided CTR.A retrospective analysis was conducted on 302 HRUS-CTR cases. Patients who were available for a phone interview and had a minimum follow-up period of one year were assessed using the Boston Carpal Tunnel Questionnaire (BCTQ). Symptom severity and functional limitations were compared before and after the procedure.Of the 302 cases screened, 111 cases had to be excluded due to unavailability for the phone call, missing data, or death. Accordingly, 191 cases were included. The average patient age was 60.4 ± 15.5 years (range: 19 to 87 years). 126 cases (66%) were female and 65 cases (34.0%) were male. Overall, there was a significant reduction of 91.9% in CTS-related symptom severity and frequency for all items recorded in the questionnaire. Similarly, a significant reduction of 84.8% in difficulty with all self-reported daily activities was found. In addition, the procedures were performed by four physicians showing no significant differences in technical success and symptoms reduction.HRUS-CTR is a safe and effective method for the treatment of CTS, showing a statistically but mostly clinically significant reduction in symptom severity and hand discomfort, which persisted 1 year after release and should therefore be considered as an alternative approach to open or endoscopic CTR.

查看原文本刊更多论文

微创超声引导下的腕管松解术：长期临床结果。

目的：在严重或难治性腕管综合征（CTS）的病例中，腕管释放（CTR）可以通过开放手术、内窥镜技术或在高分辨率超声（HRUS）引导下的微创入路进行。本研究旨在评估hrs引导CTR后的长期临床结果。材料与方法：对302例hrs - ctr病例进行回顾性分析。接受电话访谈的患者，至少有一年的随访期，使用波士顿腕管问卷（BCTQ）进行评估。比较手术前后的症状严重程度和功能限制。结果：在筛选的302例病例中，111例因无法打电话、资料缺失或死亡而被排除。因此，包括191个案件。患者平均年龄为60.4±15.5岁（19 ~ 87岁）。女性126例（66%），男性65例（34.0%）。总体而言，问卷中记录的所有项目的cts相关症状严重程度和频率显著降低了91.9%。同样，发现所有自我报告的日常活动的困难显著减少了84.8%。此外，由四位医生执行的手术在技术成功率和症状减轻方面没有显着差异。结论：HRUS-CTR是一种安全有效的治疗CTS的方法，其症状严重程度和手部不适的减轻具有统计学意义，但主要是临床意义显著，释放后持续1年，因此应考虑作为开放或内窥镜CTR的替代方法。Zusammenfassung: Ziel：先天性先天性骨髓瘤therapierefraktärem卡尔帕尔隧道综合征（CTS），常行椎间韧带横断性骨髓瘤（CTR）手术，内镜下微创手术（hochauflösender ultraschallenge - control， HRUS）微创手术。[2][1][1][1][1][1][1][1][1][1][3]。材料和方法：回顾性分析302例HRUS-CTR-Fällen durchgefhrt。患者，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡，死亡。《症状与功能》Einschränkungen wurden vor and nach dem Verfahren verglichen。Ergebnisse: Von den 302 gepr常常Fällen mussten 111 Fälle aufgrund der nichtverf gbarkeit des Telefonanrufs, fehlender Daten oder des Todes ausgeschlossen werden。老年痴呆症研究191 Fälle人类基因组学。病征：60,4±15,5（19 - 87）。126 Fälle (66%) waren weiblich和65 Fälle (34.0%) männlich。研究结果显示，cts症状明显减轻91.9%，与对照组相比有显著性差异（-häufigkeit < 0.05）。在ähnlicher Weise wurde eine显著减少84.8% der Schwierigkeiten bei allen selbstberichteten täglichen Aktivitäten festgestellt。Zusätzlich wurden die Verfahren von vier Ärzten durchgefhrt ohne Nachweis signkanter Unterschiede im technischen Erfolg and in der symptomreducdution。hrs -CTR是一种有效的治疗方法。hrs -CTR是一种有效的治疗方法。hrs -CTR是一种有效的治疗方法。hrs -CTR是一种有效的治疗方法。hrs -CTR是一种有效的治疗方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ultraschall in Der Medizin 医学-核医学

CiteScore

5.30

自引率

8.80%

发文量

228

审稿时长

6-12 weeks

期刊介绍： Ultraschall in der Medizin / European Journal of Ultrasound publishes scientific papers and contributions from a variety of disciplines on the diagnostic and therapeutic applications of ultrasound with an emphasis on clinical application. Technical papers with a physiological theme as well as the interaction between ultrasound and biological systems might also occasionally be considered for peer review and publication, provided that the translational relevance is high and the link with clinical applications is tight. The editors and the publishers reserve the right to publish selected articles online only. Authors are welcome to submit supplementary video material. Letters and comments are also accepted, promoting a vivid exchange of opinions and scientific discussions.